title: Cyclosporin A/alpha interferon-induced autologous graft-versus-host disease following peripheral blood stem cell transplant for chronic myeloid leukaemia: a clinico-pathological study.
abstract: Autologous GVHD was induced using CsA and alpha-IFN in a patient undergoing autologous PBSCT for accelerated phase CML. We demonstrated that the autologous mixed lymphocyte reactions were extremely sensitive and specific for the detection of the GVHD when compared to skin biopsy. The resultant autologous GVHD was associated with an in vitro GVL effect, suggesting a potential clinical benefit of this therapeutic manoeuvre. The post-PBSCT period was associated with an improvement in normal haemopoiesis and reduction in the proportion of blood cells expressing the Philadelphia chromosome.
authors.affiliation: Department of Haematology, University of Wales College of Medicine, Heath Park, Cardiff, UK.
authors.forename: S H
authors.initials: SH
authors.lastname: Lim
authors.forename: S
authors.initials: S
authors.lastname: Coleman
authors.forename: A
authors.initials: A
authors.lastname: Bull
authors.forename: U
authors.initials: U
authors.lastname: O'Callaghan
authors.forename: R
authors.initials: R
authors.lastname: Evely
authors.forename: M
authors.initials: M
authors.lastname: Booth
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage*; D016572:Cyclosporine / Q000008:administration & dosage*; D006086:Graft vs Host Disease / Q000139:chemically induced*; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D016898:Interferon-alpha / Q000008:administration & dosage*; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D014182:Transplantation, Autologous
chemical_list: D000970:Antineoplastic Agents; D007166:Immunosuppressive Agents; D016898:Interferon-alpha; D016572:Cyclosporine